Cancer immunotherapy developer Arcus Biosciences will float at the top of its range, scoring exits for Alphabet, Novartis, Celgene and Taiho.

Existing backer Salesforce Ventures has agreed to invest a further $100m in the cloud collaboration platform through a private placement.

ETH Zurich spinout Sensirion hopes to capture $58m by going public later this month in an offering that will position co-founders Felix Mayer and Moritz Lechner as anchor shareholders.

The diabetes treatment developer will target at least $400m from a Hong Kong offering that will allow WuXi PharmaTech to exit.

Lundbeck and Novo-backed nausea and vomiting therapy developer Acacia Pharma raised $49.6m in its initial global offering in Brussels.

The immuno-oncology therapy developer, which is backed by Novo, Sanofi, EMS and Seattle Genetics, has raised $77m in venture funding.

The corporate-backed ride hailing platform, currently valued at $5bn, has met with Indonesia Stock Exchange's CEO to discuss an initial public offering.

The anime streaming platform has raised more than $510m from investors including Tencent and Legend Capital.

The Illumina cancer testing spinout, which counts a range of other corporates as investors, is talking to advisers about a flotation this year.

The music streaming platform, whose largest shareholders include Tencent and Sony Music, will list on the New York Stock Exchange.